The growth drivers for healthcare shoes industry are that shoes foster blood circulation in lower limbs
and neuropathy has treated many patients of foot ulcers, the root cause of all foot and toe related
problems. This is reason to believe that healthcare shoes provide diabetics with better control over
disease and improves the quality of life.
Additional growth drivers to the healthcare shoes market is that leather footwear is top-of -the-line
products and share a proverbial position in today’s market place and increased focus on healthcare
regimens are pointing towards indoor and outdoor physical exercises. Online portals are also reaching
out to consumers on a broader footprint and thus the industry is traversing a lucrative growth path.
The global footwear market also has been witnessing a steady rise in fortunes and will occupy a high
brand value in the coming years. Segmentation of healthcare shoes market by type includes diabetic
shoes, rheumatoid arthritis shoes, hallux valgus and others. Segmentation of this industry by mode
of sale includes retail sales and online sales. By end user, the market includes men and women. By
distribution channel, healthcare shoes industry includes hospitals and clinics, online retail, specialty
stores, departmental stores, super and hyper markets. By geography, healthcare shoes industry
includes North America, Europe, Asia Pacific, MEA and Latin America. The key industry players in
healthcare shoes market include Francis LavigneDevelopment, Podartissrl, Dune srl, DARCO
International, Inc. and Drew Shoe Corporation.
Request Sample Copy of healthcare shoes market @
https://www.millioninsights.com/industry-reports/healthcare-shoes-market/request-sample
Market Segment:
Geographically, this report is segmented into several key Regions, with production, consumption,
revenue (million USD), market share and growth rate of Healthcare Shoes in these regions, from
2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India